|
|
Article: Appointments And Advancements.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
AdipoGenix Inc., of Boston, appointed Nils Bergenhem chief scientific officer.
Alfacell Corp., of Bloomfield, N.J., appointed Jacob Maizel and Susanna Rybak to its scientific advisory board.
ArQule Inc., of Woburn, Mass., appointed Ronald Lindsay to its board.
Avera Pharmaceuticals Inc., of San Diego, appointed Joao Siffert vice president, clinical research and development.
Biopotential Capital Inc., of Calgary, Alberta, appointed Thomas Hudson to its scientific advisory board.
Ceragenix Pharmaceuticals, of Denver, appointed Russell Allen vice president of corporate development.
Ciphergen Biosystems Inc., of Fremont, ...